Skip to main content
. 2021 Sep 16;8:714958. doi: 10.3389/fmed.2021.714958

Table 1.

Summary of candidate circRNAs as biomarkers in kidney diseases.

CircRNA Disease Specimen Expression change Significance as biomarker References
circEGLN3 RCC Kidney tissues Up As diagnostic biomarker of RCC; up-regulation predicts better prognosis (49)
circRHOBTB3 RCC Kidney tissues Down As diagnostic biomarker of RCC; down-regulation predicts poor prognosis (49)
hsa_circ_0001451 RCC Kidney tissues Down As diagnostic biomarker of RCC; down-regulation predicts poor prognosis (50)
circPCNXL2 RCC Kidney tissues Up Up-regulation predicts poor prognosis (51)
circ-ABCB10 RCC Kidney tissues Up Up-regulation predicts poor prognosis (52)
hsa_circ_001895 RCC Kidney tissues Up Up-regulation predicts poor prognosis (53)
circ_001842 RCC Kidney tissues Up Up-regulation predicts poor prognosis (54)
circPRRC2A RCC Kidney tissues Up Up-regulation predicts poor prognosis (55)
circ-EGLN3 RCC Kidney tissues Up Up-regulation predicts poor prognosis (56)
circ_0001368 RCC Kidney tissues Down Down-regulation predicts poor prognosis (57)
cRAPGEF5 RCC Kidney tissues Down Down-regulation predicts poor prognosis (58)
ciRs-126 AKI Blood Up Up-regulation predicts poor 28-day survival (59)
hsa_circ_0001334 acute kidney rejection Urine Up As diagnostic biomarker of acute rejection; up-regulation predicts poor 1-year graft function (45)
circ_101319 IMN Blood Up As diagnostic biomarker of IMN (60)
circ_002453 LN Blood Up As diagnostic biomarker of LN (61)
hsa_circ_0123190 LN Blood Down As diagnostic biomarker of LN (62)

RCC, renal cell carcinoma; AKI, acute kidney injury; IMN, idiopathic membranous nephropathy; LN, lupus nephritis.